Natural Product (NP) Details
General Information of the NP (ID: NP4522) | |||||
---|---|---|---|---|---|
Name |
Retinol
|
||||
Synonyms |
retinol; Vitamin A; all-trans-Retinol; 68-26-8; Vitamin A1; Alphalin; Axerophthol; Afaxin; Vitamin A alcohol; Oleovitamin A; Chocola A; Alphasterol; Apostavit; Aquasynth; Biosterol; Epiteliol; Ophthalamin; Agiolan; Agoncal; Anatola; Myvpack; Prepalin; Testavol; Veroftal; Aoral; Apexol; Avibon; Avitol; Axerol; Dofsol; Vaflol; Vitpex; Vogan; Disatabs Tabs; Lard Factor; all-trans-Retinyl alcohol; Bentavit A; Dohyfral A; Alcovit A; Anatola A; Vogan-Neu; A-Mulsal; Plivit A; Vi-Alpha; A-Vitan; All-trans retinol; Atars; trans-retinol; Vafol; all-trans-Vitamin A alcohol; Retrovitamin A; Homagenets Aoral; A-Sol; Hi-A-Vita; Sehkraft A; Vitamin A1 alcohol; all-trans-Vitamin A; A-Vi-Pel; ACON; ATAV; Vi-Dom-A; Super A; Anti-infective vitamin; Solu-A; Nio-A-Let; Vio-A; Antixerophthalmic vitamin; Del-VI-A; Vitavel A; Thalasphere; 11103-57-4; trans-Vitamin A alcohol; Vitamin A alcohol, all-trans-; Vitamin A1, all-trans-; Retinol, all trans-; all-trans-Vitamin A1; Vitamin A Oil; Vi-a; UNII-G2SH0XKK91; .beta.-Retinol; beta-Retinol; Vitamin A1 alcohol, all-trans-; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; MFCD00001552; CHEMBL986; G2SH0XKK91; (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; 2,4,6,8-Nonatetraen-1-ol, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-; Axerophtholum; CHEBI:17336; Wachstumsvitamin; Vitaminum A; Vitamine A; Vitavel-A; VITAMINA; NSC-122759; Retinolo [DCIT]; NCGC00017343-07; Cylasphere; Retinolo; Retinolum; Retinol [INN:BAN]; all-trans-Retinol, 95%; DSSTox_CID_3556; Hydrovit A; Retinolum [INN-Latin]; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; DSSTox_RID_77080; DSSTox_GSID_23556; Ro-a-vit; tROL; Vitamin A alcohol (VAN); Antixerophthalmisches Vitamin; Aquasol A Parenteral; Vi-alpha; Vi-alpha; Rovimix A 500; Vitamin A1 alcohol, all trans; Retinol solution; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetr aen-1-ol; CAS-68-26-8; SMR000112036; Retinol (Vit A); [11,12-3H]-Retinol; 9-cis,13-cis-Retinol; Vitamin A (USP); CCRIS 5444; HSDB 815; Vitamin A [Natural]; SR-01000763813; Retin-11,12-t2-ol (9CI); EINECS 200-683-7; NSC 122759; BRN 0403040; Tegosphere VitA; .alpha.sterol; .alpha.lin; Retinyl A; trans-Retinol acid (Vitamin A); 1rbp; Vi-.alpha.; EINECS 234-328-2; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol; (9Z)-Retinol; PubChem18446; 1gx8; Retinol-(cellular-retinol-binding-protein); Spectrum5_000993; Spectrum5_001997; Retinol, 95%, synthetic; EC 200-683-7; all-trans vitamin A alcohol; SCHEMBL3112; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-; Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol; all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; BIDD:PXR0102; 4-06-00-04133 (Beilstein Handbook Reference); MLS001066379; MLS001074751; MLS006010008; Retinol, all-trans- (8CI); SPECTRUM1501203; GTPL4053; Vitamin A; ; ; Retinoid analogues; DTXSID3023556; HMS501I08; Zinc-ethylenebis(dithiocarbamate); all-trans-13,14-Dihydro retinol; HMS1921B04; HMS2092L13; HMS2270C05; Pharmakon1600-01501203; BCP06593; HY-B1342; ZINC3831417; Tox21_110818; Tox21_202441; Tox21_300287; BDBM50092056; CCG-38864; LMPR01090001; NSC122759; NSC758150; s5592; AKOS015902578; DB00162; NSC-758150; SDCCGMLS-0066724.P001; IDI1_000486; Retinol solution, >=95.0% (HPLC); SMP2_000102; NCGC00017343-02; NCGC00017343-03; NCGC00017343-04; NCGC00017343-05; NCGC00017343-06; NCGC00017343-08; NCGC00017343-09; NCGC00017343-11; NCGC00091784-01; NCGC00091784-02; NCGC00091784-03; NCGC00091784-04; NCGC00091784-05; NCGC00091784-06; NCGC00254024-01; NCGC00259990-01; AC-11701; BS-17906; ST057232; SBI-0051690.P002; CS-0013091; C00473; C17276; D06543; 33563-EP2272846A1; 33563-EP2277869A1; 33563-EP2277870A1; 33563-EP2281813A1; 33563-EP2284174A1; 33563-EP2292608A1; 33563-EP2301936A1; 33563-EP2311820A1; 33563-EP2374791A1; AB00052248_05; 103V574; A836068; Q424976; Retinol, >=95.0% (HPLC), ~2700 U/mg; Retinol, synthetic, >=95% (HPLC), crystalline; J-014834; J-017515; Q-201926; SR-01000763813-2; SR-01000763813-4; W-104683; BRD-K22429181-001-06-8; BRD-K64634304-001-01-5; WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1; Retinol, BioXtra, >=97.5% (HPLC), ~3100 U/mg; UNII-81G40H8B0T component FPIPGXGPPPQFEQ-OVSJKPMPSA-N; 3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; 2,6,8-Nonatetraen-1-ol, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, all (E)-; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-1-nona-2,4,6,8-tetraenol; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraen-1-ol; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraen-1-ol; (2Z,4Z,6Z,8Z)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetren-1-ol; Retinol solution, 100 mug/mL +/- 25% (Refer to COA) (Ethanol with 0.1% (w/v) BHT), ampule of 1 mL, certified reference material
Click to Show/Hide
|
||||
Species Origin | Daucus carota ... | Click to Show/Hide | |||
Daucus carota | |||||
Disease | Light sensitivity impairment [ICD-11: 9D45] | Approved | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C20H30O
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCO)C)C
|
||||
InChI |
1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+
|
||||
InChIKey |
FPIPGXGPPPQFEQ-OVSJKPMPSA-N
|
||||
CAS Number |
CAS 11103-57-4
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Monodesbutyl benflumetol | Malaria | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
In-vitro Model | Plasmodium falciparum | Microorganism model | Plasmodium falciparum | |||
In-vivo Model | Clinical Trial | |||||
Experimental
Result(s) |
Monodesbutyl-benflumetol and retinol combination showed synergistic interaction in Plasmodium falciparum. | |||||
Oxacillin + Ampicillin | Click to Show/Hide the Molecular Data of This Drug | |||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [3] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
In-vitro Model | Staphylococcus aureus strains | Microorganism model | Staphylococcus aureus | |||
Staphylococcus aureus ATCC 33591 | Microorganism model | Staphylococcus aureus | ||||
Staphylococcus aureus ATCC 25923 | Microorganism model | Staphylococcus aureus | ||||
Experimental
Result(s) |
Rhein in combination with AM or OX could lead to the development of new combinations of antibiotics against MRSA infection. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Retinoic acid receptor RXR-gamma (RXRG) | Molecule Info | [4] | |
Trypanosoma Trypanothione reductase (Trypano TPR) | Molecule Info | [5] | ||
KEGG Pathway | PPAR signaling pathway | Click to Show/Hide | ||
2 | Thyroid hormone signaling pathway | |||
3 | Adipocytokine signaling pathway | |||
4 | Pathways in cancer | |||
5 | Transcriptional misregulation in cancer | |||
6 | Thyroid cancer | |||
7 | Small cell lung cancer | |||
8 | Non-small cell lung cancer | |||
Pathway Interaction Database | Regulation of Androgen receptor activity | Click to Show/Hide | ||
2 | RXR and RAR heterodimerization with other nuclear receptor | |||
3 | Retinoic acid receptors-mediated signaling | |||
4 | a6b1 and a6b4 Integrin signaling | |||
Reactome | Nuclear Receptor transcription pathway | Click to Show/Hide | ||
WikiPathways | Vitamin A and Carotenoid Metabolism | Click to Show/Hide | ||
2 | Adipogenesis | |||
3 | Nuclear Receptors |